Gemcitabine, Paclitaxel, and Cisplatin in Treating Patients With Advanced Cancer of the Urothelium

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 1998

Primary Completion Date

October 31, 2005

Study Completion Date

August 31, 2009

Conditions

Bladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter

Interventions

DRUG

cisplatin

DRUG

gemcitabine hydrochloride

DRUG

paclitaxel

PROCEDURE

conventional surgery

Trial Locations (3)

Carolinas Hematology-Oncology Associates, Charlotte

Regional Cancer Center, Greensboro

Wake Forest University Comprehensive Cancer Center, Winston-Salem

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Wake Forest University Health Sciences

OTHER

NCT00310011 - Gemcitabine, Paclitaxel, and Cisplatin in Treating Patients With Advanced Cancer of the Urothelium | Biotech Hunter | Biotech Hunter